Some of the newly added covered entities, critical access hospitals among them, were shut out of 340B pricing on drugs ...

Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.

The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.

DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral researchers can ...

Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.

A small conference with big ambitions mirrors the rapid growth of Chinese biotech, invites comparisons to U.S. biotech ...

Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.

Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.

Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining ...

The Department of Health and Human Services announced a set of new initiatives aimed at speeding up clinical trials by ...

Unpacking from vacation a couple months back, I decided to give artificial intelligence a task. I paused folding my laundry, sat down with Claude, and asked it to analyze the entirety of my genome.

Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing ...